<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation

New Report Highlights Risks of U.S. Drug Reimportation

September 6, 2019

New Report Highlights Risks of U.S. Drug Reimportation

While the reimportation of drugs into the U.S. from abroad is a popular topic among politicians and advocates looking for ways to reduce domestic healthcare costs, the research arm of the Healthcare Distribution Alliance has released a new report highlighting some little-discussed costs and risks associated with reimportation. Yourway is no stranger to logistical challenges and is monitoring this issue.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?